Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4

Author: Çelik Haydar   Arinç Emel  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.43, Iss.3, 2013-03, pp. : 263-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content